Vincent Charlon

1.4k total citations
24 papers, 1.0k citations indexed

About

Vincent Charlon is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Vincent Charlon has authored 24 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 7 papers in Physiology and 3 papers in Molecular Biology. Recurrent topics in Vincent Charlon's work include Cardiac electrophysiology and arrhythmias (7 papers), Nitric Oxide and Endothelin Effects (4 papers) and Heart rate and cardiovascular health (4 papers). Vincent Charlon is often cited by papers focused on Cardiac electrophysiology and arrhythmias (7 papers), Nitric Oxide and Endothelin Effects (4 papers) and Heart rate and cardiovascular health (4 papers). Vincent Charlon collaborates with scholars based in France, United States and Switzerland. Vincent Charlon's co-authors include Henry Krum, Reuven J. Viskoper, M. Budde, Yves Lacourcière, Milton Packer, Isaac Kobrin, Avraham Caspi, Joël de Leiris, Abraham Caspi and Barry A. Levine and has published in prestigious journals such as New England Journal of Medicine, Journal of Allergy and Clinical Immunology and The American Journal of Cardiology.

In The Last Decade

Vincent Charlon

23 papers receiving 977 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vincent Charlon France 13 697 451 319 134 128 24 1.0k
Bing-yin Wang United States 10 571 0.8× 713 1.6× 104 0.3× 241 1.8× 102 0.8× 11 1.2k
Thomas J. Wargovich United States 15 1.0k 1.4× 404 0.9× 164 0.5× 230 1.7× 334 2.6× 26 1.6k
Toyotaka Yada Japan 22 577 0.8× 645 1.4× 92 0.3× 255 1.9× 113 0.9× 48 1.4k
Yuliy Y. Chirkov Australia 24 1.2k 1.7× 485 1.1× 158 0.5× 246 1.8× 204 1.6× 71 1.7k
Charles V. Jackson United States 17 322 0.5× 190 0.4× 77 0.2× 153 1.1× 70 0.5× 29 756
Inmaculada Millás Spain 13 333 0.5× 457 1.0× 60 0.2× 184 1.4× 78 0.6× 16 872
Alan H. Singer United States 7 422 0.6× 560 1.2× 77 0.2× 124 0.9× 96 0.8× 10 871
Martin R. Siegfried United States 11 464 0.7× 706 1.6× 52 0.2× 201 1.5× 110 0.9× 13 1.3k
Michiaki Usui Japan 11 706 1.0× 749 1.7× 150 0.5× 155 1.2× 99 0.8× 16 1.5k
Bartłomiej Guzik Poland 11 272 0.4× 290 0.6× 116 0.4× 159 1.2× 72 0.6× 38 995

Countries citing papers authored by Vincent Charlon

Since Specialization
Citations

This map shows the geographic impact of Vincent Charlon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Charlon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Charlon more than expected).

Fields of papers citing papers by Vincent Charlon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Charlon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Charlon. The network helps show where Vincent Charlon may publish in the future.

Co-authorship network of co-authors of Vincent Charlon

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent Charlon. A scholar is included among the top collaborators of Vincent Charlon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent Charlon. Vincent Charlon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spertini, François, Alexander Kettner, F. de Blay, et al.. (2016). Efficacy of 2 months of allergen-specific immunotherapy with Bet v 1–derived contiguous overlapping peptides in patients with allergic rhinoconjunctivitis: Results of a phase IIb study. Journal of Allergy and Clinical Immunology. 138(1). 162–168. 50 indexed citations
2.
Packer, Milton, John J.V. McMurray, Barry M. Massie, et al.. (2005). Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study. Journal of Cardiac Failure. 11(1). 12–20. 208 indexed citations
3.
Ellahham, Samer, Wassim Choucair, Vincent Charlon, Zaid Abassi, & Karim A. Calis. (2000). Bosentan and the endothelin system in congestive heart failure. Clinical Cardiology. 23(11). 803–807. 14 indexed citations
4.
Charlon, Vincent & Isaac Kobrin. (1998). THE EFFICACY AND SAFETY OF MIBEFRADIL IN SUBGROUPS OF PATIENTS WITH CHRONIC STABLE ANGINA PECTORIS. International Journal of Clinical Practice. 52(4). 257–264. 1 indexed citations
5.
Kobrin, Isaac, et al.. (1998). Anti-Anginal and Anti-Ischemic Effects of Mibefradil, a New T-Type Calcium Channel Antagonist. Cardiology. 89(Suppl. 1). 23–32. 12 indexed citations
6.
Krum, Henry, Reuven J. Viskoper, Yves Lacourcière, M. Budde, & Vincent Charlon. (1998). The Effect of an Endothelin-Receptor Antagonist, Bosentan, on Blood Pressure in Patients with Essential Hypertension. New England Journal of Medicine. 338(12). 784–791. 449 indexed citations
7.
Schneeweiss, Adam, Isaac Kobrin, Vincent Charlon, et al.. (1998). Adding the new calcium antagonist mibefradil to patients receiving long-term β-blocker therapy results in improved antianginal and antiischemic efficacy. American Heart Journal. 135(2). 272–280. 6 indexed citations
8.
Packer, Milton, Avraham Caspi, & Vincent Charlon. (1998). MULTICENTER, DOUBLEBLIND PLACEBO CONTROLLED STUDY OF LONG TERMENDOTHELIN BLOCKADE WITH BOSENTAN IN CHRONIC HEART FAILURE RESULTS OF THE REACH-1 TRIAL. ABSTRACT. 98. 12–12. 69 indexed citations
9.
Waeber, Bernard, Isaac Kobrin, Vincent Charlon, et al.. (1998). Introduction. Cardiology. 89(1). 1–1. 1 indexed citations
10.
Charlon, Vincent, et al.. (1997). NEW DEVELOPMENTS IN DRUG THERAPY OF HYPERTENSION. Medical Clinics of North America. 81(6). 1359–1371. 8 indexed citations
11.
Kobrin, Isaac, et al.. (1997). Safety of Mibefradil, a New Once-a-Day, Selective T-Type Calcium Channel Antagonist. The American Journal of Cardiology. 80(4). 40C–46C. 21 indexed citations
12.
Charlon, Vincent, et al.. (1997). Mibefradil: A new T-channel selective calcium antagonist. Drugs of today. 33(8). 523–523. 2 indexed citations
13.
Charlon, Vincent, Christer Höglund, Isaac Kobrin, et al.. (1995). Reproducibility of angiotensin converting enzyme inhibitor induced cough: a double‐blind randomised study.. British Journal of Clinical Pharmacology. 39(2). 125–129. 11 indexed citations
14.
Coudray, Charles, Vincent Charlon, Joël de Leiris, & A. Favier. (1993). Effect of zinc deficiency on lipid peroxidation status and infarct size in rat hearts. International Journal of Cardiology. 41(2). 109–113. 35 indexed citations
15.
Kobrin, Isaac, et al.. (1993). Effects of an Orally Active Renin Inhibitor, Ro 42-5892, in Patients With Essential Hypertension. American Journal of Hypertension. 6(5_Pt_1). 349–356. 36 indexed citations
16.
Charlon, Vincent, et al.. (1990). Effect of a 5 day Trimetazidine Pretreatment in a Model of Ischemic and Reperfused Isolated Rat Heart : Spin Trapping Experiments. Advances in experimental medicine and biology. 264. 377–382. 9 indexed citations
17.
18.
Charlon, Vincent & Joël de Leiris. (1988). Ability of N-tert-butyl alpha phenylnitrone (PBN) to be used in isolated perfused heart spin trapping experiments: Preliminary studies. Basic Research in Cardiology. 83(3). 306–313. 18 indexed citations
19.
Charlon, Vincent & Joël de Leiris. (1987). Demonstration of oxygen free radical production during ischemia and reperfusion in the isolated rat heart: A spin trapping study*. Journal of Molecular and Cellular Cardiology. 19. S12–S12. 1 indexed citations
20.
Leiris, Joël de & Vincent Charlon. (1986). [Metabolic disorders generated by myocardial ischemia: implication of oxygen free radicals].. PubMed. 35(7 Pt 2). 427–31.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bing-yin Wang Breakdown of academic impact, for papers by Thomas J. Wargovich Breakdown of academic impact, for papers by Toyotaka Yada Breakdown of academic impact, for papers by Yuliy Y. Chirkov Breakdown of academic impact, for papers by Charles V. Jackson Breakdown of academic impact, for papers by Inmaculada Millás Breakdown of academic impact, for papers by Alan H. Singer Breakdown of academic impact, for papers by Martin R. Siegfried Breakdown of academic impact, for papers by Michiaki Usui Breakdown of academic impact, for papers by Bartłomiej Guzik
Rankless by CCL
2026